کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3333882 | 1213347 | 2008 | 8 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Arthropathy in Inhibitor Patients: Differences in the Joint Status
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
هماتولوژی
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Arthropathy in Inhibitor Patients: Differences in the Joint Status Arthropathy in Inhibitor Patients: Differences in the Joint Status](/preview/png/3333882.png)
چکیده انگلیسی
Inhibitor development represents the most significant complication of hemophilia treatment today. Although it has long been established that hemophilia patients with inhibitors face a higher risk (and a greater extent) of joint morbidity than their non-inhibitor counterparts, there remains a paucity of scientific data supporting this observation. Several issues need to be resolved before the risk of greater joint damage in inhibitor patients can be verified. This article explores these issues in an attempt to confirm and explain the differential joint morbidity observed between inhibitor and non-inhibitor patients. However, there remain significant gaps in our knowledge of the biology of inhibitor development, and greater understanding in this area will produce more effective therapies that might ultimately prevent or attenuate their development altogether.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Seminars in Hematology - Volume 45, Supplement 1, April 2008, Pages S42-S49
Journal: Seminars in Hematology - Volume 45, Supplement 1, April 2008, Pages S42-S49
نویسندگان
W. Keith Hoots,